沃丽汀在糖尿病视网膜病变早期眼底出血激光治疗中的应用观察  

Combined application of Jolethin and photocoagulation in treating diabetic retinopathy

作　　者：徐学农[1] 钟文[1] 张爱芳 董成芝[1] 李淑华[1] 

机构地区：[1]山东潍坊市人民医院眼科,261041 [2]山东高密骨伤科医院眼科

出　　处：《临床眼科杂志》2007年第5期432-433,共2页Journal of Clinical Ophthalmology

摘　　要：目的观察糖尿病视网膜病变早期眼底出血患者在激光治疗中联合口服沃丽汀,评价该药物对促进眼底出血吸收的疗效。方法选择Ⅰ-Ⅱ期糖尿病视网膜病变早期眼底出血患者58例(116只眼),随机分为两个治疗组。一组29例(58只眼)在激光治疗的同时口服沃丽汀,二组29例(58只眼)单纯激光治疗。治疗后观察眼底出血吸收的情况,均随访3个月。结果联合用药组的眼底出血吸收情况明显好于对照组。结论激光联合口服沃丽汀治疗糖尿病病视网膜病变早期眼底出血,可促进出血吸收。Objective To evaluate the efficacy of using Jolethin and photocoagulation for diabetic retinopathy ,Method 58 cases （ 116 eyes ） in the stage Ⅰ-Ⅱ of diabetic retinopathy were enrolled and devided into two groups in random. The experimention group were treated with Jolethin and photocoagulation. The comparision group were treated only with photocoagulation. We following up all of the patients 3 months. Results Jolethin and photocoagulation group is superior to control group. Conclusion Jolethin is an effective treatment for diabetic retinopathy .

关 键 词：糖尿病视网膜病变 沃丽汀 

分 类 号：R774.1[医药卫生—眼科] R587.1[医药卫生—临床医学]